Four structural risk factors identify most fibril-forming kappa light chains

References

• Solomon A, Weiss D T. A perspective of plasma cell dyscrasias: clinical implications of monoclonal light chains in renal disease. The Kidney in Plasma Cell Dyscrasias, L Minetti, G D'Amico, C Ponticelli. Kluwer Academic Publishers, Dordrecht 1988; 3–18
   Google Scholar
• Buxbaum J N, Chuba J V, Hellman G C, Solomon A, Gallo G R. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis. Ann Intern Med 1990; 112: 455–464
   PubMed Web of Science ®Google Scholar
• Rocca A, Khamlichi A A, Touchard G, Mougenot B, Ronco P, Denoroy L, Deret S, Preud'homme J-L, Aucouturier P, Cogne M. Sequences of V k subgroup light chains in Fanconi's syndrome. Light chain V region gene usage restriction and peculiarities in myeloma-associated Fanconi's syndrome. J Immunol 1995; 155: 3245–3252
   PubMed Web of Science ®Google Scholar
• Cohen A H. The kidney in plasma cell dyscrasias: Bence Jones cast nephropathy and light chain deposit disease. Am J Kidney Dis 1998; 32: 529–532
   PubMed Web of Science ®Google Scholar
• Gallo G R, Lazowski P, Kumar A, Vidal R, Baldwin D S, Buxbaum J N. Renal and cardiac manifestations of B-cell dyscrasias with nonamyloidotic monoclonal light chain and light and heavy chain deposition diseases. Adv Nephrol Necker Hosp 1998; 28: 355–382
   PubMedGoogle Scholar
• Clark A D, Shetty A, Soutar R. Renal failure and multiple myeloma: pathogenesis and treatment of renal failure and management of underlying myeloma. Blood Rev 1999; 13: 79–90
   PubMed Web of Science ®Google Scholar
• Deret S, Donoroy L, Lamarine M, Vidal R, Mougenot B, Frangione B, Stevens F J, Ronco P M, Aucouturier P. Kappa light chain-associated Fanconi's syndrome: molecular analysis of monoclonal immunoglobulin light chains from patients with and without intracellular crystals. Protein Eng 1999; 12: 363–369
   PubMedGoogle Scholar
• Kyle R A. Clinical aspects of multiple myeloma and related disorders including amyloidosis. Pathol (Biol) Paris 1999; 47: 148–157
   PubMedGoogle Scholar
• Stevens F J, Argon Y. Pathogenic light chains and the B-cell repertoire. Immunol Today 1999; 20: 451–457
   PubMedGoogle Scholar
• Hurle M R, Helms L R, Li L, Chan W, Wetzel R. A role for destabilizing amino acid replacements in light-chain amyloidosis. Proc Natl Acad Sci 1994; 91: 5446–5450
   PubMed Web of Science ®Google Scholar
• Wetzel R. Domain stability in immunoglobulin light chain deposition disorders. Adv Protein Chem 1997; 50: 183–242
   PubMedGoogle Scholar
• Raffen R, Dieckman L J, Szpunar M, Wunschl C, Pokkuluri P R, Dave P, Stevens Wilkins P, Cai X, Schiffer M, Stevens F J. Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains. Protein Sci 1999; 8: 509–517
   PubMed Web of Science ®Google Scholar
• Schiffer M. Molecular anatomy and the pathological expression of antibody light chains. Am J Pathol 1996; 148: 1339–1344
   PubMed Web of Science ®Google Scholar
• Klein R, Jaenichen R, Zachau H G. Expressed human immunoglobulin K genes and their hypermutation. Eur J Immunol 1993; 23: 3248–3271
   PubMed Web of Science ®Google Scholar
• Williams S C, Frippiat J-P, Tomlinson I M, Ignatovic O, Lefranc M P, Winter G. Sequence and evolution of the human germline VX, repertoire. J Mol Biol 1996; 264: 220–232
   PubMed Web of Science ®Google Scholar
• Epp O, Lattman E E, Schiffer M, Huber R, Palm W. The molecular structure of a dimer composed of the variable portions of the Bence Jones protein REI refined at 2.0 A resolution. Biochemistry 1975; 14: 4943–4952
   PubMed Web of Science ®Google Scholar
• He X M, Ruker F, Casale E, Carter D C. Structure of a human monoclonal antibody Fab fragment against gp41 of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1992; 89: 7154–7158
   PubMed Web of Science ®Google Scholar
• Fan Z-C, Shan L, Guddat L W, He X-M, Gray W R, Raison R L, Edmundson A B. Three-dimensional structure of an Fv from a human IgM immunoglobulin. J Mol Biol 1992; 228: 188–207
   PubMed Web of Science ®Google Scholar
• Huang D-B, Chang C-H, Ainsworth C, Brünger A, Eulitz M, Solomon A, Stevens F J, Schiffer M. Comparison of crystal structures of two homologous proteins: structural origin of altered domain interactions in immunoglobulin light-chain dimers. Biochemistry 1994; 33: 14848–14847
   PubMed Web of Science ®Google Scholar
• Schormann N, Murrell J R, Liepnieks J J, Benson M D. Tertiary structure of an amyloid immunoglobulin light chain protein: a proposed model for amyloid fibril formation. Proc Natl Acad Sci USA 1995; 92: 9490–9494
   PubMed Web of Science ®Google Scholar
• Uson I, Bes M T, Sheldrick G M, Schneider T R, Hartsch T, Fritz H-J. X-ray crystallography reveals stringent conservation of protein fold after removal of the only disulfide bridge from a stabilized immunoglobulin variable domain. Fold Design 1997; 2: 357–361
   PubMedGoogle Scholar
• Uson I, Pohl E, Schneider T R, Dauter Z, Schmidt A, Fritz H-J, Sheldrick G M. 1.7 A structure of the stabilized REIv mutant T39K. Application of local NCS restraints. Acta Cryst 1999; D55: 1158–1167
   Google Scholar
• Roussel A, Spinelli S, Deret S, Navaza J, Aucouturier P, Cambillau C. The structure of an entire noncovalent immunoglobulin kappa light-chain dimer (Bence Jones protein) reveals a weak and unusual constant domains association. Eur J Biochem 1999; 260: 192–199
   PubMedGoogle Scholar
• Stevens F J, Weiss D T, Solomon A A. Structural bases of light chain-related pathology. The Antibodies, M Zanetti, D Capra. Harwood Academic Publishers, Amsterdam 1999; 5: 175–208
   Google Scholar
• Johnson G, Kabat E A, Wu T T. Kabat database of sequences of proteins of immunological interest. Weir s Handbook of Experimental Immunology. I. Immunochemis-try and Molecular Immunology, 5th edition, L A Herzenberg, W M Weir, L A Herzenberg, C Blackwell. Blackwell Science Inc., Cambridge, Mass. 1996; 6.1–6.21
   Google Scholar
• Frisch C, Kolmar H, Schmidt A, Kleemann G, Reinhardt A, Pohl E, Uson I, Schneider T R, Fritz H J. Contribution of the intramolecular disulfide bridge to the folding stability of REIv, the variable domain of a human immunoglobulin kappa light chain. Fold Design 1996; 1: 431–440
   PubMedGoogle Scholar
• Toft K G, Sletten K, Husby G. The amino acid sequence of the variable region of a carbohydrate-containing amyloid fibril protein EPS (immunoglobulin light chain, type 1). Biol Chem Hoppe-Seyler 1985; 366: 617–625
   PubMed Web of Science ®Google Scholar
• Toft K G, Olstad O K, Sletten K, Westermark P. Comparative studies of two AL chains of kappa-Ill light chain origin with and without attached carbohydrate (AL So 124 and AL700). Amyloid and Amyloidosis, J B Natvig, O Forre, G Husby, A Husebekk, B Skogen, K Sletten, P Westermark. Kluwer Academic Publishers, Dordrecht 1990; 169–172
   Google Scholar
• Dwulet F E, O'Connor T P, Benson M D. Polymorphism in a kappa I primary (AL) amyloid protein (BAN). Molec Immunol 1986; 23: 73–78
   PubMed Web of Science ®Google Scholar
• Shinoda T, Kametani F, Takenawa T, Isobe T. Molecular heterogeneity of amyloid fibril proteins in primary amyloidosis. Amyloidosis, G G Glenner, E F Osserman, E P Benditt, E Calkins, A S Cohen, D Zucker-Franklin. Plenum Press, New York 1986; 151–156
   Google Scholar
• Shinoda T, Takenawa T, Hoshi A, Isobe T. Characterization of a kAL protein and two amyloidogenic kBJP in three cases of immunoglobulin amyloidosis. Amyloid and Amyloidosis, J B Natvig, O Forre, G Husby, A Husebekk, B Skogen, K Sletten, P Westermark. Kluwer Academic Publishers, Dordrecht 1990; 157–160
   Google Scholar
• Sletten K, Westermark P, Husby G. Structural studies of the variable region of immunoglobulin light-chain-type amyloid fibril proteins. Amyloidosis, G G Glenner, E F Osserman, E P Benditt, E Calkins, A S Cohen, D Zucker-Franklin. Plenum Press, New York 1986; 463–475
   Google Scholar
• Aucouturier P, Khamlichi A A, Preud'homme J-L, Bauwens M, Tuchard G, Cogne M. Complementary DNA sequence of human amyloidogenic immunoglobulin precursors. Biochem J 1992; 285: 149–152
   PubMed Web of Science ®Google Scholar
• Foss G S, Nilsen R, Cornwell G C, Husby G, Sletten K. Structural identity between a glycosylated Bence Jones protein and the autologous AL-protein. Amyloid and Amyloidosis, R Kisilevsky, M D Benson, B Frangione, J Gauldie, T J Muckle, I D Young. Parthenon Publishing, New York 1993; 235–237
   Google Scholar
• Foss G S, Nilsen R, Cornwell G C, Husby G, Sletten K. A glycosylated Bence Jones protein and its autologous amyloid light chain containing potentially amyloidogenic residues. Scand J Immunol 1998; 47: 348–354
   PubMed Web of Science ®Google Scholar
• Nyquist J, Ramstad H M, Sletten K, Husby G, Westermark P. Structural studies of two carbohydrate-containing immunoglobulin kappa light chain amyloid fibril proteins of the variable subgroup I. Amyloid and Amyloidosis, R Kisilevsky, M D Benson, B Frangione, J Gauldie, T J Muckle, I D Young. Parthenon Publishing, New York 1993; 247–249
   Google Scholar
• Wei J, Hendershot L M. Protein folding and assembly in the endoplasmic reticulum. EXS 1996; 77: 41–45
   PubMedGoogle Scholar
• Perfetti V, Ubbiali P, Vignarelli M C, Diegoli M, Fasani R, Stoppini M, Lisa A, Mangione P, Obici L, Arbustini E, Merlini G. Evidence that amyloidogenic light chains undergo antigen-driven selection. Blood 1998; 91: 2948–2954
   PubMed Web of Science ®Google Scholar
• Prado M J, Nicastri A L, Costa P L, Rockman T, Tersariol I L, Nader H B, Barros R T, Prado E B. The renal and hepatic distribution of Bence Jones proteins depend on glycosylation: a scintigraphic study in rats. Braz J Med Biol Res 1997; 30: 865–872
   PubMed Web of Science ®Google Scholar
• Stevens F J, Myatt E A, Chang C-H, Westholm F A, Eulitz M, Weiss D T, Murphy C, Solomon A, Schiffer M. A molecular model for self-assembly of amyloid fibrils: immunoglobulin light chains. Biochemistry 1995; 34: 10697–10702
   PubMed Web of Science ®Google Scholar
• Denoroy L, Deret S, Aucouturier P. Overrepresentation of the V kappa IV subgroup in light chain deposition disease. Immunol Lett 1994; 42: 63–66
   PubMed Web of Science ®Google Scholar
• Kolmar H, Frisch C, Gotze K, Fritz H-J. Immunoglobulin mutant library genetically screened for folding stability exploiting bacterial signal transduction. J Molec Biol 1995; 251: 471–476
   PubMed Web of Science ®Google Scholar
• Guijarro J I, Sunde M, Jones J A, Campbell I D, Dobson C M. Amyloid fibril formation by an SH3 domain. Proc Natl Acad Sci USA 1998; 95: 4224–4228
   PubMed Web of Science ®Google Scholar
• Chiti F, Webster P, Taddei N, Clark A, Stefani M, Ramponi G, Dobson C M. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci USA 1999; 96: 3590–3594
   PubMed Web of Science ®Google Scholar
• Dobson C M. Protein misfolding, evolution and disease. Trends Biochem Sci 1999; 24: 329–332
   PubMed Web of Science ®Google Scholar
• David D, Zouali M. Variable region light chain genes encoding human antibodies to HI V-1. Molec Immunol 1995; 32: 77–88
   PubMed Web of Science ®Google Scholar
• Solomon A, Frangione B, Franklin E C. Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda). J Clin Invest 1982; 70: 453–460
   PubMed Web of Science ®Google Scholar
• Pokkuluri P R, Solomon A, Weiss D T, Stevens F J, Schiffer M. Tertiary structure of human Λ6 light chains. Amyloid 1999; 6: 165–171
   PubMed Web of Science ®Google Scholar
• Wall J, Schell M, Murphy C, Hrncic R, Stevens F J, Solomon A. Thermodynamic instability of human lambda6 light chains: correlation with fibrillogenicity. Biochemistry 1999; 38: 14101–14108
   PubMed Web of Science ®Google Scholar
• Wilkins Stevens P, Raffen R, Hanson D K, Deng Y L, Berrios-Hammond M, Westholm F A, Murphy C, Eulitz M, Wetzel R, Solomon A, Schiffer M, Stevens F J. Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light-chain amyloid proteins. Protein Sci 1995; 4: 421–432
   PubMed Web of Science ®Google Scholar
• Engvig J P, Olsen K E, Gislefoss R E, Sletten K, Wahlstrom O, Westermark P. Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein. Scand J Immunol 1998; 48: 92–98
   PubMed Web of Science ®Google Scholar
• Solomon A, Weiss D T, Murphy C L, Hrncic R, Wall J S, Schell M. Light chain-associated amyloid deposits comprised of a novel kappa constant domain. Proc Natl Acad Sci USA 1998; 95: 9547–9551
   PubMed Web of Science ®Google Scholar
• Olsen K E, Sletten K, Westermark P. Fragmentsof the constant region of immunoglobulin light chains are constituents of AL-amyloid proteins. Biochem Biophys Res Commun 1998; 251: 642–647
   PubMed Web of Science ®Google Scholar
• Wally J, Kica G, Zhang Y, Ericsson T, Connors L H, Benson M D, Liepnieks J J, Murray J, Skinner M, Comenzo R L. Identification of a novel substitution in the constant region of a gene coding for an amyloidogenic kappa 1 light chain. Biochim Biophys Acta 1999; 1434: 49–56
   Google Scholar
• Odani S, Komori Y, Gejyo F. Structural analysis of the amyloidogenic kappa Bence Jones protein (FUR). Amyloid 1999; 6: 77–88
   PubMed Web of Science ®Google Scholar
• Eulitz M, Breuer M, Eblen A, Weiss D T, Solomon A. Production of amyloidogenic peptides from human immunoglobulin light (L)-chains. Amyloid and Amyloidosis, J B Natvig, O Forre, G Husby, A Husebekk, B Skogen, K Sletten, P Westermark. Kluwer Academic Publishers, Dordrecht 1990; 505–510
   Google Scholar
• Chance P F, Fischbeck K H. Molecular genetics of Charcot-Marie-Tooth disease and related neuropathies. Hum Mol Genet 1994; 3: 1503–1507
   PubMed Web of Science ®Google Scholar
• Warner L E, Garcia C A, Jupski J R. Hereditary peripheral neuropathies: clinical forms, genetics, and molecular mechanisms. Ann Rev Med 1999; 50: 263–275
   PubMed Web of Science ®Google Scholar
• Milstein C P, Deverson E V. Primary structure of K light chain from a human myeloma protein. Eur J Biochem 1974; 49: 377–391
   PubMedGoogle Scholar
• Levy S, Mendel E, Kon S, Avnur Z, Levy R. Mutational hot spots in Ig V region genes of human follicular lymphomas. J Exp Med 1988; 168: 475–489
   PubMed Web of Science ®Google Scholar
• Comenzo R L, Wally J, Kica G, Murray J, Ericswson T, Skinner M, Zhang Y. Clonal immunoglobulin light chain variable region germline gene use in AL amyloidosis: association with dominant amyloid-related organ involvement and survival after stem cell transplantation. Br J Haematol 1999; 106: 744–751
   PubMed Web of Science ®Google Scholar
• Yamaki S, Yoneda K, Satoh Y, Kaji H, Isobe T, Shinoda T. Complete amino acid sequence of novel proteins related to K light chain in a case with adult Fanconi syndrome. Amyloid and Amyloidosis, R Kisilevsky, M D Benson, B Frangione, J Gauldie, T J Muckle, I D Young. Parthenon Publishing, New York 1993; 250–252
   Google Scholar
• Goni F, Chuba J, Buxbaum J, Frangione B. A double monoclonal IgGlK and IgG2K in a single myeloma patient. Variation in clonal products and therapeutic responses. J Immunol 1988; 140: 551–557
   PubMed Web of Science ®Google Scholar
• Liepnieks J J, Benson M D, Dwulet F E. Comparison of the amino acid sequences of ten kappa I amyloid proteins for amyloidogenic sequences. Amyloid and Amyloidosis, J B Natvig, O Forre, G Husby, A Husebekk, B Skogen, K Sletten, P W Estermark. Kluwer Academic Publishers, Dordrecht 1990; 153–156
   Google Scholar
• Rodilla Sala E, Kratzin H D, Pick A I, Hilschmann N. Biclonality in amyloidosis patient MAL: one clone producing an amyloidogenic, the other a nonamyloidogenic kappa L-chain. Amyloid and Amyloidosis, J B Natvig, O Forre, G Husby, A Husebekk, B Skogen, K Sletten, P Westermark. Kluwer Academic Publishers, Dordrecht 1990; 161–164
   Google Scholar
• Eulitz M, Linke R P. Primary structure of the variable part of an amyloidogenic Bence Jones protein (Mev). An unusual insertion in the third hypervariable region of a human kappa immunoglobulin light chain. Hoppe-Seyler Z Physiol Chem 1982; 363: 1347–1358
   PubMedGoogle Scholar